Oncopeptides AB (publ) (ONPPF)

USD 0.27

(0.0%)

Market Cap (In USD)

55.98 Million

Revenue (In USD)

35.22 Million

Net Income (In USD)

-249.11 Million

Avg. Volume

5.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.265-0.6
PE
-1.47
EPS
-0.18
Beta Value
-0.359
ISIN
SE0009414576
CUSIP
-
CIK
-
Shares
211263657.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Sofia Heigis M.Sc.
Employee Count
-
Website
https://www.oncopeptides.com/sv
Ipo Date
2020-12-16
Details
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.